If you're a Phase 3 pharma company, serialization will be part of your strategy. Watch Sharp SVPs discuss how they approach serialization.

Polls show that 82% of clinical-stage virtual pharma companies, uncertain about the impact of serialization, are preparing for DSCSA compliance now.

With the DSCSA serialization deadline looming, get a bird’s eye view into the life of a serial number as it travels through the pharmaceutical supply…

While aggregation isn’t a regulatory requirement in the U.S., understand how the expectations of your wholesale distributor customers may impact your…

Download this PDF to learn how an Edge solution can improve your operational efficiency.

A gallery of case studies from FutureLink Barcelona.

Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.

Aggregation has the potential to add more complexity and cost to serialization, which already poses significant challenges to the life sciences…

CMOs and CPOs are critical to the life sciences supply chain’s ability to meet global serialization requirements. Learn how to prepare.

Pharma companies and CMOs must work together closely to be ready for serialization, yet there is no established commercial model. Learn about the…

See all the case studies presented at FutureLink Nashville. Learn how those from across the pharma supply chain are overcoming compliance challenges.

India-based NATCO Pharma talks about DSCSA compliance, serialization, and choosing a solution.